Hanif M, Mobarak M R, Ronan A, Rahman D, Donovan J J, Bennish M L
Department of Nephrology, Dhaka Shishu Hospital, Bangladesh.
BMJ. 1995 Jul 8;311(6997):88-91. doi: 10.1136/bmj.311.6997.88.
To determine the cause of a large increase in the number of children with unexplained renal failure.
Case-control study.
Children's hospital in Dhaka, Bangladesh.
Cases were all 339 children with initially unexplained renal failure; controls were 90 children with cause of renal failure identified; all were admitted to hospital during 35 months after January 1990.
Differences between the case and control patients in clinical and histological features and outcome; toxicological examination of 69 bottles of paracetamol from patients and pharmacies.
Compared with children with an identified cause for their renal failure, children with initially unexplained renal failure were significantly (P < 0.05) more likely to have hepatomegaly (58% v 33%), oedema (37% v 20%), and hypertension (58% v 23%); to have a higher serum creatinine concentration (mean 519 mumol/l v 347 mumol/l) and lower serum bicarbonate concentration (10.1 mmol/l v 12.4 mmol/l); to have been given a drug for fever (91% v 31%); to have ingested a brand of paracetamol shown to contain diethylene glycol (20% v 0%); and to have died in hospital (70% v 33%). Diethylene glycol was identified in 19 bottles of paracetamol, from 7 of 28 brands tested. In the 12 months after a government ban on the sale of paracetamol elixir, new cases of renal failure decreased by 54%, and cases of unexplained renal failure decreased by 84%.
Paracetamol elixirs with diethylene glycol as a diluent were responsible for a large outbreak of fatal renal failure in Bangladesh.
确定不明原因肾衰竭患儿数量大幅增加的原因。
病例对照研究。
孟加拉国达卡的儿童医院。
病例组为339名最初病因不明的肾衰竭患儿;对照组为90名已明确肾衰竭病因的患儿;所有患儿均于1990年1月后的35个月内入院。
病例组和对照组患者在临床、组织学特征及预后方面的差异;对来自患者和药房的69瓶扑热息痛进行毒理学检测。
与已明确肾衰竭病因的患儿相比,最初病因不明的肾衰竭患儿出现肝肿大(58%对33%)、水肿(37%对20%)和高血压(58%对23%)的可能性显著更高(P<0.05);血清肌酐浓度更高(平均519μmol/L对347μmol/L),血清碳酸氢盐浓度更低(10.1mmol/L对12.4mmol/L);曾服用退烧药(91%对31%);摄入了一种含二甘醇的扑热息痛品牌(20%对0%);且在医院死亡(70%对33%)。在检测的28个品牌中的7个品牌的19瓶扑热息痛中发现了二甘醇。在政府禁止销售扑热息痛酏剂后的12个月内肾衰竭新病例减少了54%,不明原因肾衰竭病例减少了84%。
以二甘醇为稀释剂的扑热息痛酏剂是孟加拉国致命肾衰竭大规模暴发的原因。